SEARCH:   Advanced

Blood, Vol. 106, Issue 12, 3747-3754, December 1, 2005 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance Blood Verhaak et al. 106: 3747 Supplemental materials for: Verhaak et al Files in this Data Supplement: Table S1 (PDF, 70 KB) - 569 probe sets representing 440 unique genes, which were identified to be significantly differentially expressed between NPM1 mutant and WT (False Discovery Rate (FDR) of 0.01). Figure S1. The 569 most significantly differentially expressed probe sets between AML cases with wild-type NPM1 and mutant NPM1 that were determined by SAM (JPG, 31.1 KB) - The levels of expression of the probe sets in the 275 cases of AML are depicted (scale bar indicates an increase (red) or a decrease (green) in the level of expression of at least 4 relative to the geometric mean)21. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020